OncoBeta - epidermal radioisotope therapy

📍 Garching, Germany🗓 Founded 2011👥 24 employees💰 Last funded Sep 2020
Medical Equipment Manufacturing🌐 oncobeta.com
Website LinkedIn
OncoBeta® GmbH located in Garching near Munich is a manufacturer and service provider of innovative medical solutions specialized in the development and commercialization of state-of-the-art therapies utilizing epidermal radioisotopes. We are very proud to be a pioneer and innovator in the epidermal radioisotope sector, presently offering a therapeutic application for physicians to treat non-melanoma skin cancer. Our current flag ship solution is the Rhenium-SCT® (Skin Cancer Therapy) a novel treatment option for basal cell carcinomas (BCCs) or squamous cell carcinomas (SCCs) based on the local irradiation of tumors with the beta-emitter Rhenium-188. Rhenium-188 is an optimal isotope for the treatment of superficial lesions such as non-melanoma skin cancers due to its practical penetration of 2-3mm in human tissue. Since the radioactive Rhenium does not come in direct contact with the patient, the Rhenium-SCT® is seen as a patient-personalised brachytherapy with minimal radiation exposition and adverse effects. The Rhenium-SCT is a CE certified method arising from over 10 years of experience and clinical studies (>700 patients, >1900 lesions). It provides non-melanoma skin cancer patients with a single-session, painless, highly-effective non- surgical treatment with excellent aesthetic results and complete remissions in up to 98,5% of all cases. We are also currently evaluating further exciting applications and treatment possibilities with rhenium-188.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
1
Switzerland
1
Frequently asked questions
Who invested in OncoBeta - epidermal radioisotope therapy?
OncoBeta - epidermal radioisotope therapy has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did OncoBeta - epidermal radioisotope therapy last raise funding?
The most recent investment in OncoBeta - epidermal radioisotope therapy recorded on gritt.io was in September 2020.
When was OncoBeta - epidermal radioisotope therapy founded?
OncoBeta - epidermal radioisotope therapy was founded in 2011.
What industry is OncoBeta - epidermal radioisotope therapy in?
OncoBeta - epidermal radioisotope therapy operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is OncoBeta - epidermal radioisotope therapy based?
OncoBeta - epidermal radioisotope therapy is headquartered in Garching, Germany.